CEO SUMMARY: Last year, Kailos Genetics stopped collecting third-party payment, dropped its prices sharply, and started marketing its genetic-screening tests directly to consumers and physicians. At the time, 100% of its revenue came from third-party payers. Today, it gets 100% of its revenue from consumers. After eliminating third-party payment, revenue dropped precipitously, but is now […]
Gene Testing Lab Goes ‘Cold Turkey,’ Stops Billing Health Plans
Tired of uncertain payment, Kailos Genetics slashes prices, goes direct to patients and docs
- By Joseph Burns
- > From the Volume XXIII No. 6 - May 2, 2016 Issue
- Tags: affordable care act, anti kickback law, cancer screening test, care contracts, clinical lab, Clinical Laboratory, dark report, dso, gene sequencing, gene test, gene testing, genetic screening, genetic test, genetic testing, genetic testing companies, genetic tests, genome sequencing, hie, lab executive, lab test, lab test pricing, lab tests, laboratory test, managed care, managed care contract, managed care contracts, Medicare, molecular testing, next-generation gene sequencing, pathologists, rejected claim, rejected claims, test menu, the affordable care act, the dark report, whole genome sequencing
